The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The Extra Domain A of Fibronectin Activates Toll-like Receptor 4
Open accessAbstract
Cellular fibronectin, which contains an alternatively spliced exon encoding type III repeat extra domain A (EDA), is produced in response to tissue injury. Fragments of fibronectin have been implicated in physiological and pathological processes, especially tissue remodeling associated with inflammation. Because EDA-containing fibronectin fragments produce cellular responses similar to those provoked by bacterial lipopolysaccharide (LPS), we examined the ability of recombinant EDA to activate Toll-like receptor 4 (TLR4), the signaling receptor stimulated by LPS. We found that recombinant EDA, but not other recombinant fibronectin domains, activates human TLR4 expressed in a cell type (HEK 293 cells) that normally lacks this Toll-like receptor. EDA stimulation of TLR4 was dependent upon co-expression of MD-2, a TLR4 accessory protein. Unlike LPS, the activity of EDA was heat-sensitive and persisted in the presence of the LPS-binding antibiotic polymyxin B and a potent LPS antagonist, E5564, which completely suppressed LPS activation of TLR4. These observations provided a mechanism by which EDA-containing fibronectin fragments promote expression of genes involved in the inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Self-citationA family of human receptors structurally related to Drosophila Toll
Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., & Bazan, J. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.588 · Cited by 1,728
Asea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling Pathways
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., & Janeway, C. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,575
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M. J., Oikawa, M., Qureshi, N., Monks, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8541 · Cited by 727
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Cited by
Items 101–141 of 141
Koga, K., & Mor, G. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00848.x · Cited by 287
Microbial recognition by Toll-like receptors
Takeda, K., & Akira, S. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2003.10.002 · Cited by 285
DAMPs as mediators of sterile inflammation in aging-related pathologies
Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283
Vermaelen, K., & Pauwels, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1384so · Cited by 283
Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278
Land, W. G. (2005) · Transplantation · doi:10.1097/01.tp.0000153160.82975.86 · Cited by 278
Lien, E., & Ingalls, R. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00001 · Cited by 273
The role of Toll-like receptors and Nod proteins in bacterial infection
PHILPOTT, D., & GIRARDIN, S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.012 · Cited by 271
Fibronectins in vascular morphogenesis
Astrof, S., & Hynes, R. O. (2009) · Angiogenesis · doi:10.1007/s10456-009-9136-6 · Cited by 271
Medvedev, A. E., Lentschat, A., Wahl, L. M., Golenbock, D. T., & Vogel, S. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5209 · Cited by 271
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases
Sîrbe, C., Rednic, S., Grama, A., & Pop, T. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179784 · Cited by 269
Youn, H. S., Lee, J. Y., Fitzgerald, K. A., Young, H. A., Akira, S., & Hwang, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3339 · Cited by 268
Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?
Scanzello, C. R., Plaas, A., & Crow, M. K. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830aba34 · Cited by 268
Iwahashi, M., Yamamura, M., Aita, T., Okamoto, A., Ueno, A., Ogawa, N., Akashi, S., Miyake, K., Godowski, P. J., & Makino, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20219 · Cited by 267
The biology of Toll-like receptors
Means, T. K., Golenbock, D. T., & Fenton, M. J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00006-x · Cited by 267
Does lipopolysaccharide-mediated inflammation have a role in OA?
Huang, Z., & Kraus, V. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.158 · Cited by 262
Shirato, K., & Kizaki, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06187 · Cited by 262
Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance
Karikó, K., Weissman, D., & Welsh, F. A. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000145666.68576.71 · Cited by 260
Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling
Erridge, C., & Samani, N. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194050 · Cited by 260
Gribar, S. C., Sodhi, C. P., Richardson, W. M., Anand, R. J., Gittes, G. K., Branca, M. F., Jakub, A., Shi, X.-H., Shah, S., Ozolek, J. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.636 · Cited by 257
Innate immunity, macrophage activation, and atherosclerosis
Yan, Z., & Hansson, G. K. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00554.x · Cited by 256
Microglia and mast cells: two tracks on the road to neuroinflammation
Skaper, S. D., Giusti, P., & Facci, L. (2012) · The FASEB Journal · doi:10.1096/fj.11-197194 · Cited by 235
Emerging role of Toll-like receptors in atherosclerosis
Curtiss, L. K., & Tobias, P. S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800056-jlr200 · Cited by 225
“Using C3H/HeJ fibroblasts with point mutation in TLR4 or C57BL/10ScCr fibroblasts with gene deletion of TLR4 transfected with TLR4 cDNA, it was found that fibrinogen, surfactant protein-A (63), fibronectin extra domain A (64), heparin sulfate (65) and soluble hyaluronan (66) are endogenous ligands for TLR4.”
Donnelly, D. J., Longbrake, E. E., Shawler, T. M., Kigerl, K. A., Lai, W., Tovar, C. A., Ransohoff, R. M., & Popovich, P. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2114-11.2011 · Cited by 219
Toll-Like Receptors: Regulators of the Immune Response in the Human Gut
Hug, H., Mohajeri, M., & La Fata, G. (2018) · Nutrients · doi:10.3390/nu10020203 · Cited by 217
The arterial microenvironment: the where and why of atherosclerosis
Yurdagul, A., Finney, A. C., Woolard, M. D., & Orr, A. W. (2016) · Biochemical Journal · doi:10.1042/bj20150844 · Cited by 185
White, E. S., & Muro, A. F. (2011) · IUBMB Life · doi:10.1002/iub.493 · Cited by 174
“TLR4 is the most-recently identified receptor for the EDA domain (64).”
BackgroundThe extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens
He, Y.-W., Li, H., Zhang, J., Hsu, C.-L., Lin, E., Zhang, N., Guo, J., Forbush, K. A., & Bevan, M. J. (2004) · Nature Immunology · doi:10.1038/ni1021 · Cited by 171
Toll-like Receptors in Defense and Damage of the Central Nervous System
Aravalli, R. N., Peterson, P. K., & Lokensgard, J. R. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9071-5 · Cited by 173
“…mice to demonstrate that β-defensin 2, SP-A, heparin sulfate, fibronectin A, hyaluronan, and fibrinogen also could function as endogenous TLR4 ligands (Okamura et al. 2001; Smiley et al. 2001; Biragyn et al. 2002; Guillot et al. 2002; Johnson et al. 2002; Termeer et al. 2002; Vabulas et al. 2002a,…”
BackgroundPharmacological properties of melanin and its function in health
ElObeid, A. S., Kamal‐Eldin, A., Abdelhalim, M. A. K., & Haseeb, A. M. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12748 · Cited by 161
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157
Zhu, Q., Zou, L., Jagavelu, K., Simonetto, D. A., Huebert, R. C., Jiang, Z.-D., DuPont, H. L., & Shah, V. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.013 · Cited by 144
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Astrof, S., Crowley, D., & Hynes, R. O. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.07.005 · Cited by 136
Extracellular Matrix Remodeling and Stiffening Modulate Tumor Phenotype and Treatment Response
Leight, J. L., Drain, A. P., & Weaver, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034431 · Cited by 131
Wurfel, M. M., Park, W. Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R. E., & Martin, T. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2570 · Cited by 130
Song, R., Zeng, Q., Ao, L., Yu, J. A., Cleveland, J. C., Zhao, K.-S., Fullerton, D. A., & Meng, X. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300116 · Cited by 86
Prophylactic and therapeutic implications of toll-like receptor ligands
Hedayat, M., Takeda, K., & Rezaei, N. (2012) · Medicinal Research Reviews · doi:10.1002/med.20214 · Cited by 76
Wang, P., Gorter, R. P., de Jonge, J. C., Nazmuddin, M., Zhao, C., Amor, S., Hoekstra, D., & Baron, W. (2018) · Glia · doi:10.1002/glia.23328 · Cited by 40
Biomaterials-Driven Sterile Inflammation
Chen, H., Agrawal, D. K., & Thankam, F. G. (2022) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2020.0253 · Cited by 41
Toll-Like Receptors in Neurodegeneration
Owens, T. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-00549-7_6 · Cited by 18
Metadata
- Authors
- Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., & Strauss, J. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 276
- Issue
- 13
- Pages
- 10229-10233
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1991731944
- Cited by
- 1,216
- References
- 28
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.